Please log in to view this page
Username
Password
The purpose of this study is to determine whether one or two four-month regimens of tuberculosis treatment are as effective as a...
ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...
HPTN 069 is a phase II, four-arm, multisite, randomized, double-blinded trial. To assess the safety and tolerability of four...
This study is currently on hold. The study is designed to characterize the pharmacokinetics of DLM using a model-based...
1077FF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...
